Indexed with PubMed and Science Citation Index (E) 
Users online: 2240 
     Home | Feedback | Login 
About Current Issue Archive Ahead of print Search Instructions Online Submission Subscribe What's New Contact  
  Navigate here 
   Next article
   Previous article 
   Table of Contents
 Resource links
   Similar in PUBMED
    Search Pubmed for
    Search in Google Scholar for
   Article in PDF (118 KB)
   Citation Manager
   Access Statistics
   Reader Comments
   Email Alert *
   Add to My List *
* Registration required (free)  

  In this article
   Article Figures

 Article Access Statistics
    PDF Downloaded595    
    Comments [Add]    

Recommend this journal


Year : 2009  |  Volume : 75  |  Issue : 7  |  Page : 54

Postinflammatory hyperpigmentation in acne

members Indian Acne Alliance, India

Correspondence Address:
Raj Kubba
Consultant Dermatologist, Kubba Clinic,10, Aradhana Enclave, Ring Road, New Delhi - 110066
Login to access the Email id

Source of Support: Production and publication of this supplement is made possible by an educational grant from Galderma India Pvt. Ltd., Conflict of Interest: Indian Acne Alliance (IAA) meetings logistics to formulate IAA consensus document DQAcne in India: Guidelines for managementDQ were supported by Galderma India Pvt. Ltd.

PMID: 19282597

Rights and PermissionsRights and Permissions

How to cite this article:
Kubba R, Bajaj A K, Thappa D M, Sharma R, Vedamurthy M, Dhar S, Criton S, Fernandez R, Kanwar A J, Khopkar U, Kohli M, Kuriyipe V P, Lahiri K, Madnani N, Parikh D, Pujara S, Rajababu K K, Sacchidanand S, Sharma V K, Thomas J. Postinflammatory hyperpigmentation in acne. Indian J Dermatol Venereol Leprol 2009;75, Suppl S1:54

How to cite this URL:
Kubba R, Bajaj A K, Thappa D M, Sharma R, Vedamurthy M, Dhar S, Criton S, Fernandez R, Kanwar A J, Khopkar U, Kohli M, Kuriyipe V P, Lahiri K, Madnani N, Parikh D, Pujara S, Rajababu K K, Sacchidanand S, Sharma V K, Thomas J. Postinflammatory hyperpigmentation in acne. Indian J Dermatol Venereol Leprol [serial online] 2009 [cited 2021 Jan 20];75, Suppl S1:54. Available from:

Postinflammatory hyperpigmentation (PIH) is a common sequela in acne patients, more so in those with skin of color. [1] PIH in acne is also called acne hyperpigmented macule (AHM). [1] AHM's were noted in 65.3% of blacks, 52.7% of Hispanics, and 47.4% of Asians in a study of acne in the USA. [1] Such data are not available for acne patients in Indians but PIH is believed to be equally common in our patients [Figure 38].

PIH appears as a discolored macule, typically in shades of brown and black, depending on the skin type and the depth, but may also express as pink, red, or purple. [2] As the term implies, PIH reflects an acquired increase in cutaneous pigmentation induced by inflammation. This acquired excess pigment may be present in the epidermis, dermis, or both. [2] Cutaneous inflammatory response results in release and subsequent oxidation of arachidonic acid to prostaglandins, leukotrienes, and other products. These products of inflammation alter the activity of both immune cells and melanocytes. In the epidermis, the effect is stimulation of melanocytes, with consequent increase in the synthesis of melanin and its transfer to the keratinocytes. In the dermis, the excess melanin is derived from pigmentary incontinence resulting from incidental damage to the melanocytes residing in the basal layer. Dermal melanin is phagocytosed by macrophages (melanophages). [2]

PIH occurs in areas of acne papules, pustules, and nodules, and its severity correlates with the severity of the inflammatory process and the underlying propensity based on the skin type. Squeezing and popping the acne lesions may contribute to PIH. Unlike acne scars, PIH is reversible. However, it may take months (3-24 months) to resolve spontaneously. The greater the contrast between the pigmented macule and the natural skin tone, the longer is the time taken for it to fade.

PIH in acne is atleast partially preventable, and this can be done by containing inflammation with timely and judicious treatment, and by sun protection. Serious treatment of PIH in acne can only be initiated after the disease has remitted. However, modalities like topical azelaic acid and topical retinoids [3] can be incorporated during the active stage. For sun protection, regular use of a noncomedogenic, oil-free, sunscreen product with an SPF of 15 or greater is recommended.

Topical treatments for PIH: There are several ways to approach this. The excess pigment can be bleached, new pigment formation can be blocked, the shedding of pigment by exfoliation can be accelerated, or a combination of the above. For bleaching excess pigment, various topical products containing hydroquinone, kojic acid, azelaic acid, retinoids, and steroids are employed. Diacneal, a retinaldehyde and glycolic acid combination cream is a new introduction for PIH in Europe. [4] For accelerating the exfoliation, options include topical products containing alpha hydroxy-acids, and chemical peels with glycolic acid, trichloracetic acid, or salicylic acid.

Nontopical treatments for PIH: Microdermabrasion and nonablative lasers have been tested in PIH in acne with no clear conclusions as to their efficacy. The decision to employ such modalities depends on complex considerations involving availability, expertise, and the degree of desperation.

  References Top

1.Taylor SC, Cook-Bolden F, Rahman Z, Strachan D. Acne vulgaris in skin of color. J Am Acad Dermatol 2002;46:S98-106.  Back to cited text no. 1  [PUBMED]  [FULLTEXT]
2.Nordlund JJ, Boissy RE, Hearing VJ, King RA, Oetting WS, Ortonne JP. The pigmentary system: Physiology and pathophysiology. 2 nd ed. Malden, MA, USA: Blackwell Publishing; 2006.  Back to cited text no. 2    
3.Grimes P, Callender V. Tazarotene cream for postinflammatory hyperpigmentation and acne vulgaris in darker skin: A double-blind, randomized vehicle controlled study. Cutis 2006;77:45-50.  Back to cited text no. 3    
4.Katsambas AD. RALGA (Diacneal) a retinaldehyde and glycolic acid association and postinflammatory hyperpigmentation: A review. Dermatology 2005;210:39-45.  Back to cited text no. 4    


  [Figure 38]


Print this article  Email this article
Previous article Next article


Online since 15th March '04
Published by Wolters Kluwer - Medknow